Investor Summary
Fund Strategy
FUND PERFORMANCE AS OF 31st December 2025
| ANNUALIZED SINCE INCEPTION | QUARTERLY | YTD |
|---|---|---|
| 10.9% | -1.5% | 3.0% |
| 2025 |
|---|
| 3.2% |
| ANNUALIZED SINCE INCEPTION | QUARTERLY | YTD |
|---|---|---|
| 10.9% | -1.5% | 3.0% |
| 2025 |
|---|
| 3.2% |
The Weitz Multi Cap Equity Fund returned -1.48% in Q4 2025 versus +2.39% for the Bloomberg U.S. 3000 Index, capping a disappointing year with +3.22% returns versus +17.21% for the benchmark. Alphabet was the standout performer as its Gemini AI surpassed expectations and moved to the front of the pack among frontier models. Life sciences holdings led by Danaher contributed positively after a difficult start to the year, while Perimeter Solutions signed a new contract with the U.S. Forest Service. Broadband investments including Liberty Broadband and Charter Communications faced headwinds from heightened industry competition. The managers fully exited CarMax due to challenging operating conditions and less visible path to improvement, while maintaining Charter exposure through Liberty Broadband as the capital investment cycle peaks. They describe 2025 as a year of missed opportunities but believe Charter's setup is improving as network upgrade spending moderates and free cash flow generation improves.
Multi-cap value investing focused on companies with durable competitive advantages and strong cash flow characteristics, emphasizing patient capital deployment during periods of temporary business challenges.
The managers express disappointment with 2025 performance, describing it as a year of missed opportunities. They believe Charter's setup is improving as capital investment cycle peaks, supporting continued share repurchases at depressed prices. They are monitoring Gartner developments closely in the evolving GenAI landscape.
| Date | Letter | Tickers | Keywords | Pitches | Quick Takes |
|---|---|---|---|---|---|
| Jan 29 2026 | 2025 Q4 | ACN, BRK-B, CDW, CHTR, CMCSA, CSGP, DHR, GOOGL, HEI, IDXX, IEX, IT, KMX, LBRDA, LH, LKQ, META, PRM, SIRI, TECH | healthcare, multi-cap, technology, Telecom, underperformance, value |
PRM KMX CHTR |
Google's Gemini AI surpassed expectations with latest release, moving to front of pack among frontier models according to industry benchmarks. Investors questioning value of Gartner's… |
| Oct 28 2025 | 2025 Q3 | - | Artificial Intelligence, Hyperscalers, infrastructure, Quality, technology |
ACN CDW ACN CDW |
The fund modestly gained as AI-driven volatility created dispersion across holdings. Managers emphasized durable AI exposure through hyperscalers like Alphabet and Meta rather than speculative… |
| Jul 27 2025 | 2025 Q2 | BRK/A, HEI, KMX | Balance Sheets, Intrinsic Value, Patience, Valuation discipline, value | HEI | The letter focuses on disciplined intrinsic value investing across market capitalizations, emphasizing patience amid short-term volatility. Management highlights valuation dispersion as an opportunity to buy… |
| Mar 31 2025 | 2025 Q1 | BRK/A, GOOG, HEI, PRM | - | - | - |
| Jan 29 2025 | 2024 Q4 | AIF CN, LBTYA, SIRI | - | - | - |
| Sep 30 2024 | 2024 Q3 | GOOG, LBRDA, LM0B GR, PRM | - | - | - |
| Jul 28 2024 | 2024 Q2 | BRK/B, CHTR, CSGP, LSXMK, ODFL | - | - | - |
| Apr 15 2024 | 2024 Q1 | CHTR, CSGP | - | - | - |
| Jan 27 2024 | 2023 Q4 | - | - | - | - |
| Aug 11 2023 | 2023 Q3 | EFX, LBRDA, META, PRM | - | - | - |
| QUARTER | THEMES | TAGS |
|---|---|---|
| 2025 Q4 |
AIAI has become a dominant theme across major equity indices, with Nvidia leading the S&P 500, ASML dominating MSCI EAFE, and TSMC leading emerging markets. The fund benefited from AI-related dynamics, particularly through Samsung's memory products experiencing substantial price increases due to DRAM shortages driven by AI demand. |
Semiconductors Memory DRAM Technology Nvidia |
BroadbandDetailed analysis of Converge ICT, Philippines fiber-optic broadband company with extensive network coverage. Company positioned to benefit from low broadband penetration and regulatory changes while transitioning from capex-heavy expansion to cash generation phase. |
Broadband Fiber Philippines Telecommunications Infrastructure | |
Used AutosCarMax faces challenging environment with constrained availability and affordability of late model used vehicles. Online competitor Carvana taking share while CarMax's omni-channel investments have yet to deliver improvements, leading to strategic changes and CEO departure. |
Auto Retail Used Cars Omni-channel Competition | |
| 2025 Q3 |
AIAI has become a dominant theme across major equity indices, with Nvidia leading the S&P 500, ASML dominating MSCI EAFE, and TSMC leading emerging markets. The fund benefited from AI-related dynamics, particularly through Samsung's memory products experiencing substantial price increases due to DRAM shortages driven by AI demand. |
Semiconductors Memory DRAM Technology Nvidia |
InfrastructureDigital 9 Infrastructure holds telecom infrastructure assets including Arqiva stake. Despite poor 2025 performance, potential capital returns and asset sales could unlock value. Infrastructure assets provide defensive characteristics. |
Telecom Infrastructure Digital Infrastructure | |
QualityThe portfolio has shifted toward higher quality businesses with better profitability, lower leverage, and less volatile earnings. Quality stocks underperformed significantly in 2025, creating attractive entry points for value investors. The manager maintains price discipline while seeking quality companies trading at discounts to intrinsic value. |
Quality Profitability Leverage Earnings | |
| 2025 Q2 |
ValueThe portfolio trades at significant discounts to the broad market, with P/E ratios 40-42% below the S&P 500. The manager believes many steady-growing companies are overlooked by markets focused on AI winners, creating opportunities in businesses with lower assumed margins and productivity that could benefit from AI adoption. |
Discount Multiples Undervalued Overlooked Opportunity |
| Date | Pitch Type | Author | Ticker | Company | Industry | Sub Industry | Bull / Bear | Exchange | Keywords | Action |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 28, 2025 | Fund Letters | Wally Weitz | CDW | CDW Corp. | Information Technology | Technology Distributors | Bull | NASDAQ | backlog, buybacks, Channel partner, Gross profit dollars, Hardware refresh, ROIC, VAR | Login |
| Jul 27, 2025 | Fund Letters | Wally Weitz | HEI | HEICO Corporation | Industrials | Aerospace & Defense | Bull | New York Stock Exchange | Acquisitions, Aerospace, aftermarket, compounding, Defense | Login |
| Jan 29, 2026 | Fund Letters | Wally Weitz | PRM | Perimeter Solutions SA | Industrials | Specialty Chemicals | Bull | New York Stock Exchange | government contracts, Pricing, Volatility-Reduction, Wildfire | Login |
| Jan 29, 2026 | Fund Letters | Wally Weitz | KMX | CarMax Inc. | Consumer Discretionary | Automotive Retail | Bear | New York Stock Exchange | Competition, Execution, Margins, Used cars | Login |
| Jan 29, 2026 | Fund Letters | Wally Weitz | CHTR | Charter Communications Inc. | Communication Services | Cable & Satellite | Bull | New York Stock Exchange | broadband, buybacks, CapEx cycle, Free Cash Flow | Login |
| Oct 28, 2025 | Fund Letters | Wally Weitz | ACN | Accenture plc | Information Technology | IT Consulting & Other Services | Bull | NYSE | AI services, Bookings, capital returns, Digital transformation, Free Cash Flow, Managed services, Utilization | Login |
| Oct 28, 2025 | Fund Letters | Wally Weitz | CDW | CDW Corp. | Information Technology | Technology Distributors | Bull | NASDAQ | backlog, buybacks, Channel partner, Gross profit dollars, Hardware refresh, ROIC, VAR | Login |
| Oct 28, 2025 | Fund Letters | Wally Weitz | ACN | Accenture plc | Information Technology | IT Consulting & Other Services | Bull | NYSE | AI services, Bookings, capital returns, Digital transformation, Free Cash Flow, Managed services, Utilization | Login |
| TICKER | COMMENTARY |
|---|---|
| ACN | Accenture is the world's leading IT consultant, with advantages stemming from their depth and breadth across products, geographies, and industries. Their revenue is split roughly in half between IT consulting and managed services. Over the last four years, Accenture's valuation has roughly halved. They've faced headwinds in IT spending and suffered from the perception that they are an AI loser. We believe that AI will cause deflationary pressure in parts of their business, but that it will be more than offset by the work required for enterprises to adopt AI. This is recently evidenced by partnerships with OpenAI and Anthropic. The AI supplier landscape is increasingly fragmented, and corporate customers need significant help adopting these technologies at scale. We believe this will drive AI suppliers and customers into Accenture's arms. The current cyclical pressures are being attributed to structural issues, which we believe is incorrect, creating an attractive long-term set-up. |
| BRK-B | Our annual pilgrimage to Omaha was running according to plan until, as we headed to the airport while listening to the final moments of the annual shareholder's meeting, Buffett dropped the bombshell: he would step down as CEO at year-end. We believe the most important aspect of Berkshire—its culture—is likely to endure. Abel inherits Berkshire's massive $382 billion cash position and will likely allocate more capital than Warren and Charlie did over much of their investing careers. |
| CDW | CDW was the second-worst performer. The IT industry continued to suffer from the pull forward of spending during COVID; however, we saw some momentum with the Windows 11 refresh and all of CDW's business lines had solid growth except for education. Despite this, overall earnings growth only exhibited modest improvement. |
| CHTR | Charter Communications sank as competitive intensity in the broadband market continued unabated, and we decided to move on from the investment for now. |
| CMCSA | Within the portfolio, stocks like AutoZone, Comcast, and Zoetis were all punished for having perceived headwinds to already lowered expectations for growth. |
| CSGP | CoStar Group is a premier information services provider to the commercial and residential real estate industries. For the last few years, we have watched the core businesses under the CoStar umbrella enjoy solid double-digit revenue growth along with consistent margin expansion. However, at the enterprise level, margins have contracted significantly due to the company's large and persistent investment in Homes.com. The results of the company's residential efforts have fallen dramatically short of its long-term expectations. |
| DHR | After lagging through the first three quarters of 2025, Danaher's stock rebounded during Q4 as bioprocessing, life science, and diagnostics demand continued to recover from a cyclical trough. On the 3Q25 call, management established conservative 2026 growth expectations. Revenue is expected to continue to lag long-term trends at 3-6% but improve throughout the year. |
| GOOGL | I'm willing to go bankrupt rather than lose this race. Larry Page, co-founder of Google |
| HEI | We've held HEI since early 2021. It's one of those quietly excellent family businesses. The Mendelsons have run it for decades, they own a meaningful stake, and they've built durable niches in aerospace parts and defense electronics. HEI was up 36% in 2025, hitting new highs on strong results across both their Flight Support and Electronic Technologies divisions. They keep doing what they do: disciplined acquisitions, high returns on capital, strong cash generation. |
| IDXX | IDXX continued to demonstrate its high-quality, defensive growth characteristics, posting robust quarterly results driven by consistent demand in its veterinary diagnostics business. |
| IEX | IDEX's stock had a welcome bounce as the company's organic growth and order book inflected higher in line with our thesis. |
| IT | Gartner is a global leader in research services, with a long history of delivering valuable insights and data to business and technology leaders. In our view, the company has the best brand in IT research, supported by its scale and a compelling customer value proposition. These advantages have driven a long history of strong organic growth and robust free-cash-flow conversion. The stock price has declined meaningfully from recent highs due to investor concerns surrounding AI-related disruption. We believe these concerns are overstated. In our view, Gartner is well-positioned to reaccelerate organic growth due to continued high customer engagement and the large opportunity to sell to new and existing customers. We took advantage of the opportunity to buy shares in this well-managed company at a bargain price. |
| KMX | CarMax is the largest used car retailer in the U.S. and has the third largest vehicle wholesale business in the U.S. alongside a large captive finance business. CarMax has underperformed both our and their own expectations over the past two quarters. We believe that the factors causing the weak results are part-macro, part-competitive, and part-operational. The used car industry is still feeling the effects of COVID. Very depressed used car supply, low but improving new car inventories, higher new and used car prices and higher rates have combined to create a perfect storm that has been a headwind to CarMax and industry-wide volumes. These largely cyclical macro factors along with the resurgence of Carvana have led to a more competitive used car market. Although the market is competitive, we believe that CarMax's customer experience, brand, scale, vertical integration, and omnichannel approach are competitive advantages. These advantages should enable them to remain a leader and to take market share in a highly fragmented market over time. As a reminder approximately 95% of the used car market is made up of players not named CarMax or Carvana. We believe that CarMax can compete and win against the franchise dealers and the smaller independent dealers as they typically have. We also believe that CarMax has all the assets to compete effectively with Carvana. We are encouraged by the operational changes the company is making to increase volumes, lower costs, and expand profitability. We anticipate that these changes, along with a normalizing used car market, will lead to a recovery in earnings. Although results may remain bumpy in the short-term, we believe CarMax is a very good business, with favorable long-term prospects. The company has a deep bench of talent, a solid balance sheet, produces significant free cash flow, and is currently buying back shares at a significant discount to our estimate of intrinsic value. |
| LBRDA | Charter Communications (down 24.1%) was again hammered, and similarly Liberty Broadband (a Charter tracking stock) was down 23.8%. With them together accounting for around 7.6% of the Fund, these positions cost us dearly. And with both now down almost 50% over the year, it is not just a quarterly phenomenon. |
| LH | Shares of leading diagnostic lab Labcorp declined amid investor concern surrounding lower-than-expected guidance, driven by delays in acquisition closings and weakness in its development pipeline, leading to a restructuring of that business. However, we maintain our conviction in the company's competitive advantages in the diagnostic space, as the company's scale allows it to be a low-cost provider with better-than-average margins. |
| META | Meta was cited as a larger position that contributed little despite what I thought was positive operating progress, representing opportunity cost in the portfolio. |
| PRM | Perimeter Solutions capped a strong 2025 by signing a new contract for its firefighting solutions and services with the U.S. Forest Service. The agreement has a longer duration, expands Perimeter's portfolio of services, and introduces a new pricing structure intended to reduce earnings and cash flow volatility tied to the severity of individual fire seasons. |
| SIRI | SiriusXM shares stalled as we await a more robust auto market and the end of the current satellite investment cycle. |
| TECH | Bio-Techne is a leader in the life sciences research market with a broad portfolio of products that are used to enable discoveries of new drugs, therapeutics, and diagnostics. These products include over 6,000 proteins, 400,000 antibody types, and 2,400 diagnostic assays. Around 80% of the business is recurring revenues. We are encouraged by the new CEO's strategy to leverage the core business and expand the company's leadership position in protein research. Consternation surrounding the health of customer research spending gave us the opportunity to buy the stock at a discount to our estimate of intrinsic value. |
| Ticker | Put/Call | Amount Bought | Shares Bought | % Change | Weight % |
|---|---|---|---|---|---|
| No Recent Buys Data | |||||
| Ticker | Put/Call | Amount Sold | Shares Sold | % Change | Weight % | Status |
|---|---|---|---|---|---|---|
| No Recent Sells Data | ||||||
| Industry | Prev Quarter % | Current Quarter % | Change |
|---|---|---|---|
| No industry data available | |||